Sarepta Therapeutics (Brazil) Analysis
| S1RP34 Stock | BRL 21.40 0.24 1.11% |
Sarepta Therapeutics is overvalued with Real Value of 19.9 and Hype Value of 21.4. The main objective of Sarepta Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Sarepta Therapeutics is worth, separate from its market price. There are two main types of Sarepta Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Sarepta Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Sarepta Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Sarepta Therapeutics stock is traded in Brazil on Sao Paulo Exchange, with the market opening at 10:00:00 and closing at 18:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Brazil. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Sarepta Therapeutics' ongoing operational relationships across important fundamental and technical indicators.
Sarepta |
Sarepta Stock Analysis Notes
The company recorded a loss per share of 22.24. Sarepta Therapeutics had not issued any dividends in recent years. Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. Sarepta Therapeutics, Inc. was incorporated in 1980 and is headquartered in Cambridge, Massachusetts. SAREPTA THERDRN operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 866 people. To find out more about Sarepta Therapeutics contact Douglas Esq at 617 274 4000 or learn more at https://www.sarepta.com.Sarepta Therapeutics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Sarepta Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Sarepta Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Sarepta Therapeutics generated a negative expected return over the last 90 days | |
| Sarepta Therapeutics has high historical volatility and very poor performance | |
| The company reported the revenue of 701.89 M. Net Loss for the year was (418.78 M) with loss before overhead, payroll, taxes, and interest of (165.84 M). | |
| Sarepta Therapeutics has accumulated about 1.74 B in cash with (443.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 21.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Sarepta Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 58.46 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sarepta Therapeutics's market, we take the total number of its shares issued and multiply it by Sarepta Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Sarepta Profitablity
Sarepta Therapeutics' profitability indicators refer to fundamental financial ratios that showcase Sarepta Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, Sarepta Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Sarepta Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Sarepta Therapeutics' profitability requires more research than a typical breakdown of Sarepta Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.82) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.61) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.61. Technical Drivers
As of the 26th of March, Sarepta Therapeutics has the Risk Adjusted Performance of (0.14), coefficient of variation of (564.96), and Variance of 17.26. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Sarepta Therapeutics, as well as the relationship between them.Sarepta Therapeutics Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Sarepta Therapeutics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Sarepta Therapeutics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Sarepta Therapeutics Predictive Daily Indicators
Sarepta Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sarepta Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 21.4 | |||
| Day Typical Price | 21.4 | |||
| Price Action Indicator | (0.12) | |||
| Period Momentum Indicator | (0.24) | |||
| Relative Strength Index | 27.04 |
Sarepta Therapeutics Forecast Models
Sarepta Therapeutics' time-series forecasting models are one of many Sarepta Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sarepta Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Sarepta Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Sarepta Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sarepta shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sarepta Therapeutics. By using and applying Sarepta Stock analysis, traders can create a robust methodology for identifying Sarepta entry and exit points for their positions.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. Sarepta Therapeutics, Inc. was incorporated in 1980 and is headquartered in Cambridge, Massachusetts. SAREPTA THERDRN operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 866 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Sarepta Therapeutics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Complementary Tools for Sarepta Stock analysis
When running Sarepta Therapeutics' price analysis, check to measure Sarepta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sarepta Therapeutics is operating at the current time. Most of Sarepta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Sarepta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sarepta Therapeutics' price. Additionally, you may evaluate how the addition of Sarepta Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |